CNC
ALXN

Citizens & Northern Corp’s Alexion Pharmaceuticals ALXN Stock Holding History

Citizens & Northern Corp’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,289
Closed -$1.92M – 104
2020
Q4 		$1.92M Sell
12,289
-29
-0.2% -$3.73K 0.85% 35
2020
Q3 		$1.41M Sell
12,318
-116
-0.9% -$12.5K 0.75% 45
2020
Q2 		$1.4M Sell
12,434
-603
-5% -$64K 0.68% 47
2020
Q1 		$1.17M Buy
13,037
+5,739
+79% +$563K 0.74% 43
2019
Q4 		$789K Sell
7,298
-5,922
-45% -$633K 0.39% 62
2019
Q3 		$1.29M Sell
13,220
-479
-3% -$54K 0.71% 48
2019
Q2 		$1.79M Sell
13,699
-309
-2% -$39.8K 1% 33
2019
Q1 		$1.89M Buy
14,008
+3,034
+28% +$377K 1.06% 30
2018
Q4 		$1.07M Sell
10,974
-2,272
-17% -$269K 0.74% 44
2018
Q3 		$1.84M Sell
13,246
-160
-1% -$20.1K 1.25% 31
2018
Q2 		$1.66M Buy
13,406
+726
+6% +$84.8K 1.18% 32
2018
Q1 		$1.41M Buy
12,680
+3,692
+41% +$441K 1.05% 39
2017
Q4 		$1.07M Buy
8,988
+529
+6% +$64.4K 0.76% 53
2017
Q3 		$1.19M Buy
8,459
+768
+10% +$104K 0.9% 49
2017
Q2 		$936K Buy
+7,691
New +$895K 0.74% 55

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citizens & Northern Corp's ALXN Position: Q1 2021 in Review

Citizens & Northern Corp sold out of Alexion Pharmaceuticals (ALXN) in Q1 2021, closing a stake of 12,289 shares — an estimated $1.92M sold.

Citizens & Northern Corp first reported a position in ALXN in Q2 2017 and held it in 15 quarters. The position peaked at $1.92M in Q4 2020. 754 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

  • Citizens & Northern Corp reported no remaining Alexion Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Citizens & Northern Corp sold 12,289 Alexion Pharmaceuticals shares in Q1 2021, an estimated $1.92M.
  • Citizens & Northern Corp first reported a position in Alexion Pharmaceuticals in Q2 2017 and held it in 15 quarters.
  • Citizens & Northern Corp's Alexion Pharmaceuticals position peaked at $1.92M in Q4 2020.
  • 754 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on Citizens & Northern Corp's 13F filing for Q1 2021, filed 11 May 2021.